Who Owns iRadimed Stock?
NASDAQ: IRMDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 62.67%
- Held by insiders
- 35.18%
- Institutional holders
- 308
- Institutions 62.7%
- Insiders 35.2%
- Public and other 2.2%
Who owns iRadimed stock?
Institutional investors own about 62.7% of iRadimed's shares, spread across 308 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 35.18% of IRMD.
The largest institutional holders are Blackrock Inc. (7.57%), Kayne Anderson Rudnick Investment Management LLC (3.10%) and Renaissance Technologies, LLC (3.08%). Together, the top 10 institutions control 29.9% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their IRMD positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IRMD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 967.83K | 7.57% | 0.0% |
| Kayne Anderson Rudnick Investment Management LLC | 396.98K | 3.10% | +13.7% |
| Renaissance Technologies, LLC | 394.41K | 3.08% | -10.5% |
| Copeland Capital Management, LLC | 391.86K | 3.06% | +9.1% |
| Vanguard Capital Management LLC | 364.94K | 2.85% | +1.8% |
| T. Rowe Price Investment Management, Inc. | 318.68K | 2.49% | +24.1% |
| Geode Capital Management, LLC | 290.11K | 2.27% | +1.2% |
| Nine Ten Capital Management LLC | 256.56K | 2.01% | -23.3% |
| Dimensional Fund Advisors LP | 229.34K | 1.79% | +1.4% |
| State Street Corporation | 221.51K | 1.73% | +8.3% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IRMD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 264.37K | 2.07% |
| iShares Trust-iShares Russell 2000 ETF | 213.57K | 1.67% |
| Virtus Equity Trust-Virtus KAR Small-Cap Growth Fund | 136.77K | 1.07% |
| T. Rowe Price Small-Cap Value Fund, Inc. | 116.90K | 0.91% |
| JNL Series Trust-JNL Multi-Manager Small Cap Growth Fund | 102.57K | 0.80% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 92.57K | 0.72% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 91.10K | 0.71% |
| iShares Trust-iShares Russell 2000 Growth ETF | 80.35K | 0.63% |
| TR PRICE-Price (T.Rowe) U.S. Small-Cap Value Equity Trust | 76.62K | 0.60% |
| Fidelity Advisor Series I-Fidelity Advisor Small Cap Fund | 65.27K | 0.51% |
Frequently asked questions
Who is the largest shareholder of iRadimed?
Blackrock Inc. is the largest institutional shareholder of IRMD, owning 7.57% of shares outstanding (967.83K shares) as of its latest 13F filing.
What percentage of iRadimed is owned by institutions?
Institutions own about 62.7% of IRMD shares and 96.7% of the public float.
How much of iRadimed do insiders own?
Insiders, such as officers and directors, own about 35.18% of IRMD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.